Back
Boundless Bio, Inc. BOLD · Insights
Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer ther... Price2.46
Market Cap57.04 M
Float13.64 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro